Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00758550 · ClinicalTrials.gov registry record · Phase 4
Visual Function After Bilateral Implantation of AcrySof® Toric
A Phase 4 study of Visual Function, sponsored by Alcon Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT00758550 is a Phase 4 study of Visual Function that has completed, run by Alcon Research. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00758550, a Phase 4 study of Visual Function, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study was to evaluate visual function of AcrySof Toric and AcrySof Natural Intraocular Lenses (IOLs) following implant for replacement of cataract.
Conditions Studied
Interventions
- DEVICE AcrySof® Toric IOL
- DEVICE AcrySof Natural
Study Locations (1)
Texas
- Alcon Call Center - Fort Worth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2007-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00758550
The ClinicalTrials.gov registry entry for NCT00758550 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alcon Research, which has 275 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Visual Function appearing as the primary indexed condition, and to 2 interventions - of which AcrySof® Toric IOL is the first listed.
NCT00758550 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT00758550 about?
NCT00758550 is a clinical study titled "Visual Function After Bilateral Implantation of AcrySof® Toric". The objective of this study was to evaluate visual function of AcrySof Toric and AcrySof Natural Intraocular Lenses (IOLs) following implant for replacement of cataract.
What is the current status of trial NCT00758550?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2007-04.
What conditions does trial NCT00758550 study?
This clinical trial studies the following conditions: Visual Function.
What interventions are being tested in trial NCT00758550?
The interventions under investigation include: AcrySof® Toric IOL (DEVICE), AcrySof Natural (DEVICE).
Who is sponsoring clinical trial NCT00758550?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00758550 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Visual Function
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.